2,4-thiazolidinedione has been researched along with Anemia in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Insulin resistance is a characteristic feature of uremia." | 2.42 | Treatment of insulin resistance in uremia. ( Nesić, V; Stefanović, V; Stojimirović, B, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stefanović, V | 1 |
| Nesić, V | 1 |
| Stojimirović, B | 1 |
1 review available for 2,4-thiazolidinedione and Anemia
| Article | Year |
|---|---|
Treatment of insulin resistance in uremia.
Topics: Anemia; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus, Type 2; Erythrop | 2003 |